Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells-Reference-Cited by-同舟云学术

Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells

Published:2020-01 Issue:1 Volume:28 Page:129-141
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hiramoto Takafumi,Tahara Maino,Liao Jiyuan,Soda Yasushi,Miura Yoshie,Kurita Ryo,Hamana Hiroshi,Inoue Kota,Kohara Hiroshi,Miyamoto Shohei,Hijikata Yasuki,Okano Shinji,Yamaguchi Yoshiyuki,Oda Yoshinao,Ichiyanagi Kenji,Toh Hidehiro,Sasaki Hiroyuki,Kishi Hiroyuki,Ryo Akihide,Muraguchi Atsushi,Takeda Makoto,Tani Kenzaburo

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Ministry of Health, Labour and Welfare of Japan

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. SLAM (CDw150) is a cellular receptor for measles virus;Tatsuo;Nature,2000

2. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus;Noyce;PLoS Pathog.,2011

3. Measles;Rota;Nat. Rev. Dis. Primers,2016

4. Targeted cell entry of lentiviral vectors;Funke;Mol. Ther.,2008

5. Generation of measles virus with a segmented RNA genome;Takeda;J. Virol.,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing;Molecular Therapy - Methods & Clinical Development;2024-09

2. Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives;Regulatory Mechanisms in Biosystems;2023-08-28

3. Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives;REGUL MECH BIOSYST;2023

4. Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave;Molecular Diagnosis & Therapy;2022-06-28

5. miRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency;Molecular Therapy - Methods & Clinical Development;2022-03